Te Ahumairangi Investment Management Ltd
Source: SEC Form 13F · as of Mar 2026Te Ahumairangi Investment Management Ltd holds 19 biotech & pharma companies tracked by BioSniper, totaling $91.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$91.5M
| Company | Shares | Value |
|---|---|---|
| DVADaVita Inc. | 59,330 | $9.1M |
| JNJJOHNSON & JOHNSON | 33,864 | $8.3M |
| MRKMerck & Co., Inc. | 63,569 | $7.6M |
| GILDGILEAD SCIENCES, INC. | 46,856 | $6.5M |
| AZNASTRAZENECA PLC | 32,489 | $6.3M |
| PFEPFIZER INC | 211,112 | $5.9M |
| DGXQuest Diagnostics Incorporated | 30,222 | $5.9M |
| GMOptec International, Inc. | 71,372 | $5.3M |
| CAHCardinal Health Inc. | 24,064 | $5.1M |
| ABBVAbbVie Inc. | 22,818 | $5.0M |
| BMYBRISTOL MYERS SQUIBB CO | 75,355 | $4.6M |
| MCKMcKesson Corporation | 5,212 | $4.5M |
| ELVElevance Health Inc. | 13,615 | $4.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,329 | $3.3M |
| ROIVRoivant Sciences Ltd. | 92,667 | $2.6M |
| LLYELI LILLY & Co | 2,735 | $2.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,135 | $2.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,122 | $2.2M |
| WSTWest Pharmaceutical Services Inc. | 1,770 | $444K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.